Current Net Margin
—
Regencell Bioscience Holdings Limited currently has a net profit margin of —. Net margin is a key efficiency ratio that measures what percentage of each dollar of revenue actually results in profit for the company.
Historical Margin Data
Quarterly and annual profitability trends
| Date | Revenue ($B) | Net Income ($B) | Net Margin | Change (bps) |
|---|---|---|---|---|
| 2025-06-30 | — | -0.00 | — | — |
| 2024-12-29 | — | -0.00 | — | — |
| 2024-06-30 | — | -0.00 | — | — |
| 2023-12-30 | — | -0.00 | — | — |
| 2023-06-30 | — | -0.00 | — | — |
| 2022-12-30 | — | -0.00 | — | — |
| 2022-06-30 | -2.34 | -0.00 | 0.17% | — |
| 2021-12-30 | — | -0.00 | — | — |
| 2021-06-30 | — | -0.00 | — | — |
| 2020-12-30 | — | -0.00 | — | — |
| 2020-06-30 | — | -0.00 | — | — |
| 2019-12-30 | — | -0.00 | — | — |
* Net margin = (Net Income / Total Revenue) * 100. Based on official SEC filings.